AAV-CRISPR/Cas9–Mediated Depletion of VEGFR2 Blocks Angiogenesis In Vitro
Wenyi Wu(Smith-Kettlewell Eye Research Institute), Hetian Lei(Massachusetts Eye and Ear Infirmary)
Cited by 40
Related Papers
Genome editing abrogates angiogenesis in vivo
|Nature Communications|2017|145
Expression of PDGFRα Is a Determinant of the PVR Potential of ARPE19 Cells
|Investigative Ophthalmology & Visual Science|2011|59
A Novel Function of p53
|American Journal Of Pathology|2012|34
Blockade of MDM2 with inactive Cas9 prevents epithelial to mesenchymal transition in retinal pigment epithelial cells
|Laboratory Investigation|2019|17
Leverage of nuclease-deficient CasX for preventing pathological angiogenesis
|Molecular Therapy — Nucleic Acids|2023|6